Education and Training

Accredited Continuing Medical Education

• Neurocysticercosis: Diagnosis and Management of Patients Living in the United States This course is designed to educate clinicians about neurocysticercosis (NCC) in the United States. Lesson 1 will cover basic epidemiology of the disease, including life cycle of Taenia solium (the causative agent), risk factors for acquiring the disease, the burden of disease, and prevention of the disease. Lesson 2 will discuss presentation, diagnosis, and evaluation techniques for patients with NCC. Lesson 3 will describe appropriate management of patients with NCC. Lesson 4 will include three case studies, to present an opportunity to think critically about diagnosis and management of NCC, particularly in complex cases.
• Chagas Disease: What U.S. Clinicians Need to Know This course is designed to educate clinicians about Chagas disease in the United States. Lesson 1 covers basic epidemiology, including a detailed life cycle of Trypanosoma cruzi (the causative agent) and risk factors for acquiring the disease. Lesson 2 discusses phases and manifestations of Chagas disease. Lesson 3 covers laboratory diagnosis, clinical evaluation, and treatment options. This course also includes three patient scenarios so that participants have the opportunity to think critically about diagnosing and treating Chagas.
• Online CE Module for Chagas, Leish and Cysti This continuing education module, offered through Emory University's Rollins School of Public Health, is intended to train US health providers who care for patients who are Latin American immigrants. This CE module reviews the three most common and serious parasitic diseases among Latin American immigrants: Chagas disease, Cysticercosis, Leishmaniasis and also reviews some cultural competency concepts.
• Malaria 101 for the Health Care Provider This course is a web-based training course designed to teach clinicians about the epidemiology, prevention, diagnosis, and treatment of malaria. Lesson 1 provides some background on malaria and discusses the epidemiology of malaria. Lesson 2 discusses the prevention of malaria in travelers. Lesson 3 reviews the diagnosis and treatment of malaria. After the lessons, three clinical scenarios will be presented.
• Malaria Cases in the U.S. Reach 40-Year High: Information and Guidance for Clinicians The number of malaria cases reported in the United States in 2011 was the largest since 1971, representing a 14% increase from 2010 and a 48% increase from 2008. The majority of malaria infections occurred among persons who traveled to regions with ongoing malaria transmission. Imported malaria can reintroduce malaria into regions where the disease is not endemic and environmental conditions are present that support the lifecycle of the parasite. During this COCA call, a CDC subject matter expert will describe malaria prevention strategies aimed at reducing the risk of malaria in travelers, discuss the diagnosis of malaria in patients with suspect malaria, and explain the treatment options for confirmed malaria cases.

Laboratory Training

• CDC Bottle Bioassay The CDC bottle bioassay determines if a particular formulation (combination of the active ingredient in the insecticide and inactive ingredients) is able to kill an insect vector, such as a mosquito, at a specific location at a given time. It can detect resistance to insecticides in mosquitoes and other insects. The technique is simple, rapid, and economical, compared with alternatives. The results can help guide the choice of insecticide used for spraying.